Impact of COVID-19 pandemic on tuberculosis laboratory services in Europe

RECOMMENDED

Tuberculosis

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

★ 2 Recommended by Dr Martin Frey, Faculty Member

Lancet Glob Health.

Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, Baguelin M, Lees JA, Whittles LK, Ainslie KEC, Bhatt S, Boonyasiri A, Brazeau NF, Cattarino L, Cooper LV, Coupland H, Cuomo-Dannenburg G, Dighe A, Djaafara BA, Donnelly CA, Eaton JW, van Elsland SL, FitzJohn RG, Fu H, Gaythorpe KAM, Green W, Haw DJ, Hayes S, Hinsley W, Imai N, Laydon DJ, Mangal TD, Mellan TA, Mishra S, Nedjati-Gilani G, Parag KV, Thompson HA, Unwin HJT, Vollmer MAC, Walters CE, Wang H, Wang Y, Xi X, Ferguson NM, Okell LC, Churcher TS, Arinaminpathy N, Ghani AC, Walker PGT, Hallett TB

doi: 10.1016/S2214-109X(20)30288-6.

RECOMMENDED

Pulmonary Fibrosis

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L

doi: 10.1016/j.jcf.2020.07.022.

RECOMMENDED

Respiratory Tract Infection

Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases

★ 2 Recommended by Dr Martin Frey, Faculty Member

Eur Respir J.

Giannouchos TV, Sussman RA, Mier JM, Poulas K, Farsalinos K

doi: 10.1183/13993003.02144-2020.

COMMENTED

Respiratory Tract Infection

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

Thorax.

Flower B, Brown JC, Simmons B, Moshe M, Frise R, Penn R, Kugathasan R, Petersen C, Daunt A, Ashby D, Riley S, Atchison CJ, Taylor GP, Satkunarajah S, Naar L, Klaber R, Badhan A, Rosadas C, Khan M, Fernandez N, Sureda-Vives M, Cheeseman HM, O'Hara J, Fontana G, Pallett SJC, Rayment M, Jones R, Moore LSP, McClure MO, Cherepanov P, Tedder R, Ashrafian H, Shattock R, Ward H, Darzi A, Elliot P, Barclay WS, Cooke GS

doi: 10.1136/thoraxjnl-2020-215732.

RECOMMENDED

Respiratory Tract Infection

Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients

★ 2 Recommended by Dr Martin Frey, Faculty Member

J Clin Med.

Ko JH, Joo EJ, Park SJ, Baek JY, Kim WD, Jee J, Kim CJ, Jeong C, Kim YJ, Shon HJ, Kang ES, Choi YK, Peck KR

doi: 10.3390/jcm9072268.

RECOMMENDED

Respiratory Tract Infection

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

★ 1 Recommended by Dr Martin Frey, Faculty Member

doi: 10.1016/S1473-3099(20)30200-0.

RECOMMENDED

Interstitial Lung Disease

Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the COVID-19 pandemic

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest.

Wong AW, Fidler L, Marcoux V, Johannson KA, Assayag D, Fisher JH, Hambly N, Kolb M, Morisset J, Shapera S, Ryerson CJ

doi: 10.1016/j.chest.2020.04.019.

RECOMMENDED

Further Publications

The COVID-19 Pandemic's Impact on Critical Care Resources and Providers: A Global Survey

★ 2 Recommended by Dr Martin Frey, Faculty Member

Chest.

Wahlster S, Sharma M, Lewis AK, Patel PV, Hartog C, Jannotta G, Blissitt P, Kross EK, Kassebaum NJ, Greer DM, Curtis JR, Creutzfeldt CJ

doi: 10.1016/j.chest.2020.09.070.

RECOMMENDED

Tuberculosis

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members^# of ESCMID Study Group for Mycobacterial Infections (ESGMYC)

★ 2 Recommended by Dr Martin Frey, Faculty Member

Eur Respir J.

Min Ong CW, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Choon Heng BH, Ippolito G, Jankovic M, Kim HY, Klintz SR, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini M, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D

doi: 10.1183/13993003.01727-2020.

Related content

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the COVID-19 pandemic

The COVID-19 Pandemic's Impact on Critical Care Resources and Providers: A Global Survey

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for Mycobacterial Infections (ESGMYC)

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members^# of ESCMID Study Group for Mycobacterial Infections (ESGMYC)